View Product
> Fingertip textured
> Powder free
> Not made with natural rubber latex
> Chemo drugs tested
> Lab chemical tested
> Ambidextrous
> Standard cuff
> Violet blue colour
GloveOn Protect gloves have antimicrobial properties that can kill up to 99.999% of microbes.* Suitable to be used to help prevent healthcare-associated infections and in any situation where cross contamination is a major concern.
* Test reports available on request.
| Reorder Code | Size |
|---|---|
| AMG38XS | X-Small |
| AMG38SS | Small |
| AMG38MM | Medium |
| AMG38LL | Large |
| AMG38XL | X-Large |
| Glove Properties | Measurement |
|---|---|
| Length | ≥230 |
| Thickness at Palm (centre of Palm) | 0.07 ± 0.02 |
| Thickness at Finger (13mm ± 3mm from tip) | 0.09 ± 0.02 |
| Physical Properties | Before Ageing | After Ageing |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥400 |
| Inspection Levels and AQL | Inspection Level | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4.0 |
| Tensile Strength | S2 | 4.0 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4.0 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Packaging | |
|---|---|
| Configuration | 200 gloves per box for XS to L 180 gloves per box for XL 10 boxes per carton |
| Regulatory Compliance | |
|---|---|
| Regulations | MDD 93/42/EEC REACH ROHS Directive 2002/95/EC EU 2016/425 ARTG 164563 EC 1935/2004 |
| International Standards | |
|---|---|
| Standards | ASTM F1671 ASTM D7907 ASTM D6319 ASTM D412 ASTM D5151 ASTM D6124 ASTM D6978 ISO 10993 part 5, 10 & 11 EN 455 part 1, 2, 3 & 4 EN 16523-1 EN ISO 374-1 (Type C) EN 374 part 2, 4 & 5 EN 420 EN 1186 ISO 13130 CEN/TS 14234 HACCP Certified |
| Manufacturing Accreditations | |
|---|---|
| Accreditations | ISO 9001 EN ISO 13485 |
| Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05, Test Report PN 141960) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 5.6 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 38.2 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
| WARNING: Carmustine and Thiotepa, at the tested concentration, degraded Protect nitrile glove at 5.6 minutes and 38.2 minutes, respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such decision. | |
